Wordt geladen...
Antibody–Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned
Antibody–drug conjugates are an emerging class of biopharmaceuticals changing the landscape of targeted chemotherapy. These conjugates combine the target specificity of monoclonal antibodies with the anti-cancer activity of small-molecule therapeutics. Several antibody–drug conjugates have received...
Bewaard in:
| Gepubliceerd in: | Clin Pharmacokinet |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6252075/ https://ncbi.nlm.nih.gov/pubmed/29188435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-017-0619-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|